Atlas FDA

SUPARTZ FX & VISCO-3

FDA premarket approval P980044/S036 · decided 2017-01-19

Approval details

PMA number
P980044
Supplement
S036
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SUPARTZ FX & VISCO-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2016-12-23
Decision date
2017-01-19
Days to decision
27 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
Relocate within the manufacturing site the production of a component used in the manufacture of SUPARTZ FX and VISCO-3.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15